CORRECTED - Allergan licenses drug for night-time urination | Reuters
Links shared publicly online about this topic.
- 1,272total visits
CORRECTED - Allergan licenses drug for night-time urination | Reuters
(Corrects symptoms of overactive bladder in last paragraph) * Allergan gets global rights to sell intra-nasal drug * To pay privately held Serenity $43 mln upfront * To make up to $122 mln in other
View full resource at reuters.com
Tags: Urinary System, Overactive Bladder, Drug, Allergan, Urology
Most Recently Shared on April 1, 2010 at 1:44 pm By:
Allergan is licensing a late-stage urology therapy; $43M upfront, $122M in milestones. http://bit.ly/91DhV5
Advertisement
